|
JP4521738B2
(ja)
*
|
1999-03-30 |
2010-08-11 |
住友化学株式会社 |
ベンゾチアゾール化合物、その製造法、液晶組成物及び液晶素子
|
|
US7056917B2
(en)
|
2001-04-26 |
2006-06-06 |
Daiichi Pharmaceutical Co., Ltd. |
Drug efflux pump inhibitor
|
|
WO2003029210A2
(en)
*
|
2001-10-04 |
2003-04-10 |
Merck & Co. Inc. |
Heteroaryl substituted tetrazole modulators of metabotropic glutamate receptor-5
|
|
WO2003033477A1
(en)
*
|
2001-10-12 |
2003-04-24 |
Warner-Lambert Company Llc |
Alkynlated fused ring pyrimidine compounds as matrix metalloprotease-13 inhibitor
|
|
WO2004007469A1
(en)
*
|
2002-07-12 |
2004-01-22 |
Warner-Lambert Company Llc |
New alkynylated quinazolin compounds as mmp-13 inhibitors
|
|
EP1434585A1
(en)
*
|
2001-10-12 |
2004-07-07 |
Warner-Lambert Company LLC |
Alkyne matrix metalloproteinase inhibitors
|
|
MXPA04003008A
(es)
*
|
2001-10-12 |
2004-07-16 |
Warner Lambert Co |
Compuestos pirimidina de anillo fusionado alquinilado como inhibidores de metaloproteasa 13 de la matriz.
|
|
US6962922B2
(en)
|
2001-10-12 |
2005-11-08 |
Warner-Lambert Company Llc |
Alkynylated quinazoline compounds
|
|
US6894057B2
(en)
|
2002-03-08 |
2005-05-17 |
Warner-Lambert Company |
Oxo-azabicyclic compounds
|
|
US6747147B2
(en)
|
2002-03-08 |
2004-06-08 |
Warner-Lambert Company |
Oxo-azabicyclic compounds
|
|
AU2003221969A1
(en)
|
2002-04-19 |
2003-11-03 |
3M Innovative Properties Company |
Materials for organic electronic devices
|
|
PA8578101A1
(es)
*
|
2002-08-13 |
2004-05-07 |
Warner Lambert Co |
Derivados de heterobiarilo como inhibidores de metaloproteinasa de la matriz
|
|
DE10250708A1
(de)
*
|
2002-10-31 |
2004-05-19 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Alkin-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel
|
|
US7452911B2
(en)
|
2002-10-31 |
2008-11-18 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds
|
|
PL376733A1
(pl)
*
|
2002-11-01 |
2006-01-09 |
Takeda Pharmaceutical Company Limited |
Środek do zapobiegania lub leczenia neuropatii
|
|
US7192657B2
(en)
*
|
2003-04-15 |
2007-03-20 |
3M Innovative Properties Company |
Ethynyl containing electron transport dyes and compositions
|
|
US7271406B2
(en)
|
2003-04-15 |
2007-09-18 |
3M Innovative Properties Company |
Electron transport agents for organic electronic devices
|
|
WO2005100331A2
(en)
*
|
2004-04-14 |
2005-10-27 |
Ranbaxy Laboratories Limited |
Antidiabetic agents
|
|
MX2009006728A
(es)
*
|
2006-12-20 |
2009-09-09 |
Novartis Ag |
Heterociclos de 5 miembros 2-sustituidos como inhibidores de scd.
|
|
JPWO2011061996A1
(ja)
*
|
2009-11-17 |
2013-04-04 |
田辺三菱製薬株式会社 |
ビフェニル誘導体の製法
|
|
IN2015DN02241A
(enExample)
*
|
2012-09-26 |
2015-08-21 |
Api Corp |
|
|
HK1224288A1
(zh)
|
2013-11-08 |
2017-08-18 |
Bayer Pharma Aktiengesellschaft |
作为类糜蛋白酶抑制剂的取代的尿嘧啶
|
|
KR102412220B1
(ko)
|
2013-12-24 |
2022-06-23 |
온코타르티스, 아이엔씨. |
벤즈아미드 및 니코틴아미드 화합물 및 이를 사용하는 방법
|
|
CN106146391A
(zh)
*
|
2015-04-15 |
2016-11-23 |
中国科学院上海药物研究所 |
5-芳香炔基取代的苯甲酰胺类化合物及其制备方法、药物组合物和用途
|
|
AU2017294231B2
(en)
*
|
2016-07-05 |
2021-09-09 |
Guangzhou Maxinovel Pharmaceuticals Co., Ltd |
Aromatic acetylene or aromatic ethylene compound, intermediate, preparation method, pharmaceutical composition and use thereof
|
|
AU2018398887B2
(en)
|
2017-12-29 |
2024-03-14 |
Guangzhou Maxinovel Pharmaceuticals Co., Ltd |
Aromatic vinyl or aromatic ethyl derivative, preparation method therefor, intermediate, pharmaceutical composition, and application
|